News for Soleno Therapeutics, Inc. (SLNO)

SLNO's DCCR shows potential as a breakthrough treatment for Prader-Willi Syndrome, with FDA priority review.Dependence on the success of a single product candi

On February 27, 2025, Soleno Therapeutics Inc (SLNO), a biopharmaceutical company focused on developing treatments for rare diseases, announced its financial re

REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) ( SLNO), a biopharmaceutical company developing novel therapeutics

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a significant transaction involving Soleno Therapeutics Inc. The firm added

Nantahala Capital Management, LLC (Trades, Portfolio), a prominent investment firm, executed a significant stock transaction on December 31, 2024. The firm adde

Significant Transaction on December 31, 2024 On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a notable reduction in its hol

Significant Transaction in Surrozen Inc On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a notable transaction involving Sur

Significant Transaction on December 31, 2024 On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a notable transaction by incre

Significant Stock Transaction by Nantahala Capital Management, LLC (Trades, Portfolio) On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfoli

Significant Stock Acquisition by Nantahala Capital Management On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a notable tra

Transaction Overview On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a significant move by increasing its stake in Altisource P

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a strategic move by acquiring 3,493,235 shares of Apyx Medical Corp (APYX) at a

Transaction Overview On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in Cellectar B

Significant Transaction on December 31, 2024 On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a noteworthy transaction by ac

Recent Transaction Overview On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a significant transaction involving Zevra Thera

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a significant move by increasing its stake in InspireMD Inc (NSPR). The firm ad

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a strategic move by increasing its stake in DarioHealth Corp (NASDAQ: DRIO). Th

Transaction Overview On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a strategic move by increasing its stake in Eventbrite Inc

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a strategic move by increasing its stake in OptiNose Inc (NASDAQ: OPTN). The fi